These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 16393242)
1. Barrett's esophagus and cytokine polymorphisms-confusion about the content in the abstract/results section compared to the table given in a recent manuscript. Leodolter A Am J Gastroenterol; 2005 Dec; 100(12):2814. PubMed ID: 16393242 [No Abstract] [Full Text] [Related]
2. IL-1 RN polymorphism is not associated with Barrett's esophagus and esophageal adenocarcinoma. Moons LM; Siersema PD; Kuipers EJ; van Vliet AH; Kusters JG Am J Gastroenterol; 2005 Dec; 100(12):2818. PubMed ID: 16393246 [No Abstract] [Full Text] [Related]
3. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295 [TBL] [Abstract][Full Text] [Related]
4. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study. Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297 [TBL] [Abstract][Full Text] [Related]
5. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence]. Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680 [TBL] [Abstract][Full Text] [Related]
6. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus. Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552 [TBL] [Abstract][Full Text] [Related]
7. Short segment Barrett's esophagus: ignorance may be bliss. Richter JE Am J Gastroenterol; 2006 Jun; 101(6):1183-5. PubMed ID: 16771934 [TBL] [Abstract][Full Text] [Related]
8. Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma. Ochs-Balcom HM; Falk G; Grady WM; Kinnard M; Willis J; Elston R; Eng C; Chak A Transl Res; 2007 Jul; 150(1):3-17. PubMed ID: 17585859 [TBL] [Abstract][Full Text] [Related]
10. Growth factors and oncogenes in Barrett's oesophagus and gastric metaplasia. Filipe MI; Jankowski J Endoscopy; 1993 Nov; 25(9):637-41. PubMed ID: 8119221 [No Abstract] [Full Text] [Related]
11. Frequency of Barrett's neoplasia after initial negative endoscopy with biopsy: a long-term histopathological follow-up study. Vieth M; Schubert B; Lang-Schwarz K; Stolte M Endoscopy; 2006 Dec; 38(12):1201-5. PubMed ID: 17163319 [TBL] [Abstract][Full Text] [Related]
12. The incidence of esophageal adenocarcinoma in Barrett's esophagus has been overestimated. Desai TK; Singh J; Samala N; Subbiah P Am J Gastroenterol; 2011 Jul; 106(7):1364-5; author reply 1365-6. PubMed ID: 21731021 [No Abstract] [Full Text] [Related]
14. Barrett's esophagus: results of a multicentric survey. G.O.S.P.E. (Gruppo Operativo per lo Studio delle Precancerosi Esofagee. Bonelli L Endoscopy; 1993 Nov; 25(9):652-4. PubMed ID: 8119225 [No Abstract] [Full Text] [Related]
15. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322 [TBL] [Abstract][Full Text] [Related]
16. Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway? Corley DA Gastrointest Endosc; 2008 Mar; 67(3):399-401. PubMed ID: 18294502 [No Abstract] [Full Text] [Related]
17. A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinoma. MacDonald K; Porter GA; Guernsey DL; Zhao R; Casson AG Cancer Epidemiol; 2009 Jul; 33(1):37-40. PubMed ID: 19679045 [TBL] [Abstract][Full Text] [Related]
18. Barrett's esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma. Guardino JM; Khandwala F; Lopez R; Wachsberger DM; Richter JE; Falk GW Am J Gastroenterol; 2006 Oct; 101(10):2187-93. PubMed ID: 17032182 [TBL] [Abstract][Full Text] [Related]
19. Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation. Wongsurawat VJ; Finley JC; Galipeau PC; Sanchez CA; Maley CC; Li X; Blount PL; Odze RD; Rabinovitch PS; Reid BJ Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):509-16. PubMed ID: 16537709 [TBL] [Abstract][Full Text] [Related]
20. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling. Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]